US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on June 17 for "Regulation of eIF4E activity for migraine therapy" (Texas Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,756, issued on June 17, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Regulation of eIF4E activity for migraine therapy" was invented by Greg Dussor (Dallas) and Jacob E. Lackovic (Dallas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a method of preventing, treating, or inhibiting migraine in a subject, by administering to the subject an amount of first therapeutic selected from cercosporamide, eFT508, or 4EGI-1 sufficient to prevent, treat, or inhibit said migraine. The present disclosure further provides a composition including at least two of cercosporamide, eFT508, or 4EGI-1, ...